prof. dr. E. (Edo) Vellenga

Professor

prof. dr. E. (Edo) Vellenga
Telephone:
E-mail:
e.vellenga umcg.nl

Research

Publications
  1. Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

    Dutch-Belgian Hemato-Oncology, Swiss Grp Clinical Canc Res SAKK, Ossenkoppele, G. J., Breems, D. A., Stuessi, G., Van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., De Jongh, E., Klein, S. K., Van der Klift, M., Van Marwijk Kooy, M., Maertens, J., Micheaux, L., Van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., Van der Velden, W. J. F. M., De Weerdt, O., Pabst, T., Manz, M. & Lowenberg, B., 4-Feb-2020, In : Leukemia. 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia-Manero, G., Buckstein, R., Santini, V., Diez-Campelo, M., Finelli, C., Cazzola, M., Ilhan, O., Sekeres, M. A., Falantes, J. F., Arrizabalaga, B., Salvi, F., Giai, V., Vyas, P., Bowen, D., Selleslag, D., DeZern, A. E., Jurcic, J. G., Germing, U., Goetze, K. S., Quesnel, B., Beyne-Rauzy, O., Cluzeau, T., Voso, M-T., Mazure, D., Vellenga, E., Greenberg, P. L., Hellstrom-Lindberg, E., Zeidan, A. M., Ades, L., Verma, A., Savona, M. R., Laadem, A., Benzohra, A., Zhang, J., Rampersad, A., Dunshee, D. R., Linde, P. G., Sherman, M. L., Komrokji, R. S. & List, A. F., 9-Jan-2020, In : New England Journal of Medicine. 382, 2, p. 140-151 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells

    Wierenga, A. T. J., Cunningham, A., Erdem, A., Lopera, N. V., Brouwers-Vos, A. Z., Pruis, M., Mulder, A. B., Gunther, U. L., Martens, J. H. A., Vellenga, E. & Schuringa, J. J., 27-Dec-2019, In : Cancer & Metabolism. 7, 1, 17 p., 11.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia

    In 't Hout, F. E. M., Gerritsen, M., Bullinger, L., van der Reijden, B. A., Huls, G., Vellenga, E. & Jansen, J. H., 19-Dec-2019, In : Haematologica. 105, 5, 21 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

View all (505) »

ID: 156947